Two Co-Existing Germline Mutations P53 V157D and PMS2 R20Q Promote Tumorigenesis in a Familial Cancer Syndrome

Cancer Letters - Ireland
doi 10.1016/j.canlet.2013.08.032
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Germline Mutations in Japanese Familial Pancreatic Cancer Patients

Oncotarget
Oncology
2016English

No Evidence of Germline PTEN Mutations in Familial Prostate Cancer

Journal of Medical Genetics
Genetics
2000English

Germline ETV6 Mutations in Familial Thrombocytopenia and Hematologic Malignancy

Nature Genetics
Genetics
2015English

Lack of Germline CDK6 Mutations in Familial Melanoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

The Evolution of Tumors in Mice and Humans With Germline P53 Mutations

Cold Spring Harbor Symposia on Quantitative Biology
BiochemistryGeneticsMolecular Biology
2015English

Breast Cancer Phenotype in Women With TP53 Germline Mutations: A Li-Fraumeni Syndrome Consortium Effort

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Germline-Activating RRAS2 Mutations Cause Noonan Syndrome

American Journal of Human Genetics
Genetics
2019English

Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Germline Mutations in Pancreatic Cancer Become Better Defined

CA - A Cancer Journal for Clinicians
OncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy